CTA
AVXL icon

Colonial Trust Advisors’s Anavex Life Sciences AVXL Stock Holding History

Colonial Trust Advisors’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-200
Closed -$1.14K – 687
2024
Q3 		$1.14K Hold
200
– – ﹤0.01% 707
2024
Q2 		$844 Hold
200
– – ﹤0.01% 703
2024
Q1 		$1.02K Hold
200
– – ﹤0.01% 858
2023
Q4 		$1.86K Hold
200
– – ﹤0.01% 719
2023
Q3 		$1.31K Hold
200
– – ﹤0.01% 758
2023
Q2 		$1.63K Hold
200
– – ﹤0.01% 761
2023
Q1 		$1.71K Hold
200
– – ﹤0.01% 740
2022
Q4 		$1.85K Buy
+200
New +$2.14K ﹤0.01% 733

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $1.74B AUM 32.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return